112 related articles for article (PubMed ID: 12121653)
21. X-ray crystal structure localizes the mechanism of inhibition of an IL-36R antagonist monoclonal antibody to interaction with Ig1 and Ig2 extra cellular domains.
Larson ET; Brennan DL; Hickey ER; Ganesan R; Kroe-Barrett R; Farrow NA
Protein Sci; 2020 Jul; 29(7):1679-1686. PubMed ID: 32239732
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of recombinant human interleukin-22.
Nagem RA; Colau D; Dumoutier L; Renauld JC; Ogata C; Polikarpov I
Structure; 2002 Aug; 10(8):1051-62. PubMed ID: 12176383
[TBL] [Abstract][Full Text] [Related]
23. Interactions among the components of the interleukin-10 receptor complex.
Krause CD; Mei E; Mirochnitchenko O; Lavnikova N; Xie J; Jia Y; Hochstrasser RM; Pestka S
Biochem Biophys Res Commun; 2006 Feb; 340(2):377-85. PubMed ID: 16364239
[TBL] [Abstract][Full Text] [Related]
24. One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β.
Blech M; Peter D; Fischer P; Bauer MM; Hafner M; Zeeb M; Nar H
J Mol Biol; 2013 Jan; 425(1):94-111. PubMed ID: 23041424
[TBL] [Abstract][Full Text] [Related]
25. Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody.
Karpusas M; Lucci J; Ferrant J; Benjamin C; Taylor FR; Strauch K; Garber E; Hsu YM
Structure; 2001 Apr; 9(4):321-9. PubMed ID: 11525169
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism.
Bleicher L; de Moura PR; Watanabe L; Colau D; Dumoutier L; Renauld JC; Polikarpov I
FEBS Lett; 2008 Sep; 582(20):2985-92. PubMed ID: 18675809
[TBL] [Abstract][Full Text] [Related]
27. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
28. Structural analysis of cytokines comprising the IL-10 family.
Zdanov A
Cytokine Growth Factor Rev; 2010 Oct; 21(5):325-30. PubMed ID: 20846897
[TBL] [Abstract][Full Text] [Related]
29. The structure of interleukin-2 complexed with its alpha receptor.
Rickert M; Wang X; Boulanger MJ; Goriatcheva N; Garcia KC
Science; 2005 Jun; 308(5727):1477-80. PubMed ID: 15933202
[TBL] [Abstract][Full Text] [Related]
30. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
31. Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1.
Redpath NT; Xu Y; Wilson NJ; Fabri LJ; Baca M; Andrews AE; Braley H; Lu P; Ireland C; Ernst RE; Woods A; Forrest G; An Z; Zaller DM; Strohl WR; Luo CS; Czabotar PE; Garrett TP; Hilton DJ; Nash AD; Zhang JG; Nicola NA
Biochem J; 2013 Apr; 451(2):165-75. PubMed ID: 23384096
[TBL] [Abstract][Full Text] [Related]
32. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.
Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM
Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694
[TBL] [Abstract][Full Text] [Related]
33. Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratope.
Lowe DC; Gerhardt S; Ward A; Hargreaves D; Anderson M; Ferraro F; Pauptit RA; Pattison DV; Buchanan C; Popovic B; Finch DK; Wilkinson T; Sleeman M; Vaughan TJ; Mallinder PR
J Mol Biol; 2011 Feb; 406(1):160-75. PubMed ID: 21167836
[TBL] [Abstract][Full Text] [Related]
34. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
Wang X; Rickert M; Garcia KC
Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
[TBL] [Abstract][Full Text] [Related]
35. cDNA cloning, genomic structure, molecular characterization and mRNA expression analysis of the Pekin duck interleukin-10 receptor 1.
Yao Q; Fischer KP; Tyrrell DL; Gutfreund KS
Int J Immunogenet; 2012 Feb; 39(1):55-67. PubMed ID: 22098679
[TBL] [Abstract][Full Text] [Related]
36. Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.
Stanfield R; Cabezas E; Satterthwait A; Stura E; Profy A; Wilson I
Structure; 1999 Feb; 7(2):131-42. PubMed ID: 10368281
[TBL] [Abstract][Full Text] [Related]
37. Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production.
Gasche C; Grundtner P; Zwirn P; Reinisch W; Shaw SH; Zdanov A; Sarma U; Williams LM; Foxwell BM; Gangl A
J Immunol; 2003 Jun; 170(11):5578-82. PubMed ID: 12759436
[TBL] [Abstract][Full Text] [Related]
38. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
[TBL] [Abstract][Full Text] [Related]
39. Bacterial production and structure-functional validation of a recombinant antigen-binding fragment (Fab) of an anti-cancer therapeutic antibody targeting epidermal growth factor receptor.
Kim JH; Sim DW; Park D; Jung TG; Lee S; Oh T; Ha JR; Seok SH; Seo MD; Kang HC; Kim YP; Won HS
Appl Microbiol Biotechnol; 2016 Dec; 100(24):10521-10529. PubMed ID: 27470143
[TBL] [Abstract][Full Text] [Related]
40. Identification and functional characterization of a second chain of the interleukin-10 receptor complex.
Kotenko SV; Krause CD; Izotova LS; Pollack BP; Wu W; Pestka S
EMBO J; 1997 Oct; 16(19):5894-903. PubMed ID: 9312047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
